Resverlogix Corp. (RVX.TO)
CAD 0.05
(12.5%)
CAD 0.05
(12.5%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -0.01 USD | 85.8% |
| 2021 | -0.10 USD | -992.86% |
| 2020 | 0.01 USD | -98.04% |
| 2019 | 0.57 USD | 165.52% |
| 2018 | -0.87 USD | -107.14% |
| 2017 | -0.42 USD | 4.55% |
| 2016 | -0.44 USD | -120.0% |
| 2015 | -0.20 USD | 9.09% |
| 2014 | -0.22 USD | 68.12% |
| 2013 | -0.69 USD | -218.97% |
| 2012 | 0.58 USD | 300.0% |
| 2011 | -0.29 USD | 32.56% |
| 2010 | -0.43 USD | 35.82% |
| 2009 | -0.67 USD | -9.84% |
| 2008 | -0.61 USD | 44.04% |
| 2007 | -1.09 USD | -57.97% |
| 2006 | -0.69 USD | -155.56% |
| 2005 | -0.27 USD | -92.86% |
| 2004 | -0.14 USD | -59.27% |
| 2003 | -0.09 USD | -83.89% |
| 2002 | -0.05 USD | -1038.1% |
| 2001 | -0.00 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q1 | -0.02 USD | -722.58% |
| 2023 Q2 | -0.01 USD | 22.8% |
| 2023 Q3 | -0.02 USD | -10.07% |
| 2022 Q1 | -0.01 USD | 86.15% |
| 2022 Q2 | -0.00 USD | 83.33% |
| 2022 Q3 | -0.01 USD | -306.25% |
| 2022 FY | - USD | 85.8% |
| 2022 Q4 | 0.00 USD | 147.69% |
| 2021 Q2 | -0.01 USD | -11000.0% |
| 2021 Q1 | 0.00 USD | 0.0% |
| 2021 FY | - USD | -992.86% |
| 2021 Q4 | -0.07 USD | -217.89% |
| 2021 Q3 | -0.02 USD | -100.0% |
| 2020 Q3 | -0.02 USD | 46.58% |
| 2020 FY | - USD | -98.04% |
| 2020 Q1 | 0.04 USD | 100.0% |
| 2020 Q2 | -0.03 USD | -173.0% |
| 2019 Q4 | 0.02 USD | -95.83% |
| 2019 Q3 | 0.48 USD | 2300.0% |
| 2019 Q2 | 0.02 USD | 106.9% |
| 2019 Q1 | -0.29 USD | -317.27% |
| 2019 FY | - USD | 165.52% |
| 2018 Q3 | -0.21 USD | 25.0% |
| 2018 Q4 | -0.07 USD | 66.9% |
| 2018 Q1 | -0.04 USD | 74.27% |
| 2018 Q2 | -0.28 USD | -625.39% |
| 2018 FY | - USD | -107.14% |
| 2017 FY | - USD | 4.55% |
| 2017 Q4 | -0.15 USD | -56.09% |
| 2017 Q3 | -0.10 USD | 31.36% |
| 2017 Q2 | -0.14 USD | -157.35% |
| 2017 Q1 | -0.05 USD | 54.67% |
| 2016 Q3 | -0.14 USD | -127.27% |
| 2016 Q1 | -0.05 USD | 45.97% |
| 2016 Q2 | -0.06 USD | -35.09% |
| 2016 FY | - USD | -120.0% |
| 2016 Q4 | -0.12 USD | 14.29% |
| 2015 Q3 | -0.04 USD | -220.67% |
| 2015 Q4 | -0.08 USD | -133.15% |
| 2015 FY | - USD | 9.09% |
| 2015 Q2 | 0.03 USD | -68.05% |
| 2015 Q1 | 0.09 USD | 584.02% |
| 2014 Q1 | -0.00 USD | 99.11% |
| 2014 FY | - USD | 68.12% |
| 2014 Q3 | -0.04 USD | 50.57% |
| 2014 Q4 | -0.02 USD | 50.38% |
| 2014 Q2 | -0.08 USD | -4552.94% |
| 2013 FY | - USD | -218.97% |
| 2013 Q3 | -0.02 USD | 96.36% |
| 2013 Q4 | -0.19 USD | -850.0% |
| 2013 Q2 | -0.55 USD | -1051.56% |
| 2013 Q1 | 0.06 USD | -66.0% |
| 2012 FY | - USD | 300.0% |
| 2012 Q4 | 0.17 USD | 221.43% |
| 2012 Q3 | -0.14 USD | -27.27% |
| 2012 Q2 | -0.11 USD | -241.61% |
| 2012 Q1 | -0.03 USD | 66.39% |
| 2011 Q4 | -0.10 USD | -26.05% |
| 2011 FY | - USD | 32.56% |
| 2011 Q2 | -0.02 USD | 48.74% |
| 2011 Q3 | -0.08 USD | -366.26% |
| 2011 Q1 | -0.03 USD | 63.15% |
| 2010 Q3 | -0.10 USD | -5.15% |
| 2010 Q4 | -0.09 USD | 13.7% |
| 2010 FY | - USD | 35.82% |
| 2010 Q1 | -0.05 USD | 76.85% |
| 2010 Q2 | -0.10 USD | -105.4% |
| 2009 Q2 | -0.13 USD | -563.27% |
| 2009 Q4 | -0.20 USD | -81.82% |
| 2009 Q3 | -0.11 USD | 15.38% |
| 2009 Q1 | -0.02 USD | 90.67% |
| 2009 FY | - USD | -9.84% |
| 2008 Q3 | -0.17 USD | 10.53% |
| 2008 Q1 | -0.03 USD | 86.17% |
| 2008 Q2 | -0.19 USD | -472.29% |
| 2008 Q4 | -0.21 USD | -23.53% |
| 2008 FY | - USD | 44.04% |
| 2007 Q2 | -0.27 USD | -592.31% |
| 2007 Q4 | -0.24 USD | 27.27% |
| 2007 Q3 | -0.33 USD | -22.22% |
| 2007 Q1 | -0.04 USD | 75.63% |
| 2007 FY | - USD | -57.97% |
| 2006 FY | - USD | -155.56% |
| 2006 Q4 | -0.16 USD | -33.33% |
| 2006 Q3 | -0.12 USD | -64.38% |
| 2006 Q1 | -0.01 USD | 82.07% |
| 2006 Q2 | -0.07 USD | -652.58% |
| 2005 Q2 | -0.05 USD | -1013.95% |
| 2005 FY | - USD | -92.86% |
| 2005 Q4 | -0.05 USD | 27.48% |
| 2005 Q3 | -0.07 USD | -55.74% |
| 2005 Q1 | -0.00 USD | 89.71% |
| 2004 Q4 | -0.04 USD | -45.14% |
| 2004 Q2 | -0.02 USD | -602.94% |
| 2004 Q1 | -0.00 USD | 77.63% |
| 2004 FY | - USD | -59.27% |
| 2004 Q3 | -0.03 USD | -20.5% |
| 2003 Q3 | -0.01 USD | 49.21% |
| 2003 Q2 | -0.02 USD | 18.03% |
| 2003 FY | - USD | -83.89% |
| 2003 Q4 | -0.02 USD | -56.7% |
| 2003 Q1 | -0.02 USD | -109.91% |
| 2002 Q3 | -0.00 USD | 48.68% |
| 2002 Q4 | -0.01 USD | -184.62% |
| 2002 FY | - USD | -1038.1% |
| 2002 Q1 | -0.00 USD | 0.0% |
| 2002 Q2 | -0.01 USD | -406.67% |
| 2001 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Appili Therapeutics Inc. | -0.03 CAD | 54.487% |
| Eupraxia Pharmaceuticals Inc. | -1.58 CAD | 99.101% |
| Helix BioPharma Corp. | -0.21 CAD | 93.238% |
| Microbix Biosystems Inc. | -0.00 CAD | -4633.333% |
| Medicenna Therapeutics Corp. | -0.37 CAD | 96.162% |
| Satellos Bioscience Inc. | -0.18 CAD | 92.111% |
| Oncolytics Biotech Inc. | -0.41 CAD | 96.537% |
| Sernova Corp. | -0.13 CAD | 89.077% |